These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11770090)

  • 1. Indomethacin versus radiation therapy for heterotopic ossification after hip arthroplasty.
    D'Lima DD; Venn-Watson EJ; Tripuraneni P; Colwell CW
    Orthopedics; 2001 Dec; 24(12):1139-43. PubMed ID: 11770090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy].
    Kölbl O; Flentje M; Eulert J; Barthel T; Knelles D; Kraus U
    Strahlenther Onkol; 1997 Dec; 173(12):677-82. PubMed ID: 9454352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is prophylaxis for heterotopic ossification with radiation therapy after THR associated with early loosening or carcinogenesis?
    Pakos EE; Papadopoulos DV; Gelalis ID; Tsantes AG; Gkiatas I; Kosmas D; Tsekeris PG; Xenakis TA
    Hip Int; 2020 Sep; 30(5):559-563. PubMed ID: 30990093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indomethacin for prevention of heterotopic ossification after hip arthroplasty. A randomized comparison between 4 and 8 days of treatment.
    Dorn U; Grethen C; Effenberger H; Berka H; Ramsauer T; Drekonja T
    Acta Orthop Scand; 1998 Apr; 69(2):107-10. PubMed ID: 9602763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined radiotherapy and indomethacin for the prevention of heterotopic ossification after total hip arthroplasty.
    Pakos EE; Stafilas KS; Tsekeris PG; Politis AN; Mitsionis G; Xenakis TA
    Strahlenther Onkol; 2009 Aug; 185(8):500-5. PubMed ID: 19652932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of radiation dose in a combined therapeutic protocol for the prevention of heterotopic ossification after total hip replacement.
    Pakos EE; Tsekeris PG; Paschos NK; Pitouli EJ; Motsis EK; Xenakis TA
    J BUON; 2010; 15(1):74-8. PubMed ID: 20414931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial comparing early postoperative irradiation vs. the use of nonsteroidal antiinflammatory drugs for prevention of heterotopic ossification following prosthetic total hip replacement.
    Kölbl O; Knelles D; Barthel T; Kraus U; Flentje M; Eulert J
    Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):961-6. PubMed ID: 9392532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General short-term indomethacin prophylaxis to prevent heterotopic ossification in total hip arthroplasty.
    Hofmann S; Trnka HJ; Metzenroth H; Frank E; Ritschl P; Salzer M
    Orthopedics; 1999 Feb; 22(2):207-11. PubMed ID: 10037334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No effective prophylaxis of heterotopic ossification with short-term ibuprofen.
    Koorevaar CT; Hu HP; Lemmens A; van Kampen A
    Arch Orthop Trauma Surg; 1999; 119(3-4):183-5. PubMed ID: 10392515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty.
    Legenstein R; Bösch P; Ungersböck A
    Arch Orthop Trauma Surg; 2003 Apr; 123(2-3):91-4. PubMed ID: 12664317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indomethacin compared with localized irradiation for the prevention of heterotopic ossification following surgical treatment of acetabular fractures.
    Burd TA; Lowry KJ; Anglen JO
    J Bone Joint Surg Am; 2001 Dec; 83(12):1783-8. PubMed ID: 11741055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty.
    Romanò CL; Duci D; Romanò D; Mazza M; Meani E
    J Arthroplasty; 2004 Jan; 19(1):14-8. PubMed ID: 14716644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low rates of heterotopic ossification after resurfacing hip arthroplasty with use of prophylactic radiotherapy in select patients.
    Kruser TJ; Kozak KR; Cannon DM; Platta CS; Heiner JP; Illgen RL
    J Arthroplasty; 2012 Aug; 27(7):1349-53. PubMed ID: 22245125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam.
    Barthel T; Baumann B; Nöth U; Eulert J
    Acta Orthop Scand; 2002 Dec; 73(6):611-4. PubMed ID: 12553505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol.
    Pakos EE; Pitouli EJ; Tsekeris PG; Papathanasopoulou V; Stafilas K; Xenakis TH
    Int Orthop; 2006 Apr; 30(2):79-83. PubMed ID: 16482442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of heterotopic ossification after total hip replacement: a prospective comparison of indomethacin and salmon calcitonin in 60 patients.
    Günal I; Hazer B; Seber S; Göktürk E; Turgut A; Köse N
    Acta Orthop Scand; 2001 Oct; 72(5):467-9. PubMed ID: 11728072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-course indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty.
    Amstutz HC; Fowble VA; Schmalzried TP; Dorey FJ
    J Arthroplasty; 1997 Feb; 12(2):126-32. PubMed ID: 9139094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of heterotopic ossification in hip arthroplasty. The influence of the duration of treatment.
    Vastel L; Kerboull L; Dejean O; Courpied JP; Kerboull M
    Int Orthop; 1999; 23(2):107-10. PubMed ID: 10422027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naproxen in the prevention of heterotopic ossification after total hip replacement.
    Vielpeau C; Joubert JM; Hulet C
    Clin Orthop Relat Res; 1999 Dec; (369):279-88. PubMed ID: 10611883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HO prevention and the combined therapeutic protocol--do we really need it?
    Kose KC; Cebesoy O; Altinel L
    Int Orthop; 2007 Feb; 31(1):133-4. PubMed ID: 16900355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.